Encompass Health Corporation (EHC) Current Ratio
- Current ratio · latest quarter: Value 1.19×; Formula and calculation Current assets / current liabilities..
Current ratio
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Current ratio · latest quarter | 1.19× | Current assets / current liabilities. $1.04B ÷ $873.40M ≈ 1.19× |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Current assets | 1.04B USD | Assets, Current |
| Current obligations | 873.40M USD | Liabilities, Current |
| Cash and equivalents | 107.70M USD | Cash and Cash Equivalents, at Carrying Value |
| Short-term securities | (m) | |
| Customer receivables | (m) | Accounts Receivable, after Allowance for Credit Loss, Current |
| Inventory | (m) | |
| Payables | 221.60M USD | Accounts Payable, Current |
| Borrowing debt due within one year | (m) | Long-term Debt, Current Maturities |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Current assets (USD) | Current obligations (USD) | Cash and equivalents (USD) | Short-term securities (USD) | Customer receivables (USD) | Inventory (USD) | Payables (USD) | Borrowing debt due within one year (USD) | Current ratio |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $1.04B | $873.40M | $107.70M | (m) | (m) | (m) | $221.60M | (m) | 1.19× |
| 2026-03-31 | $1.03B | $876.80M | $110.50M | (m) | (m) | (m) | $204.00M | (m) | 1.17× |
| 2025-12-31 | $905.90M | $836.40M | $72.20M | (m) | (m) | (m) | $178.20M | (m) | 1.08× |
| 2025-09-30 | $869.80M | $762.00M | $48.70M | (m) | (m) | (m) | $138.40M | (m) | 1.14× |
| 2025-06-30 | $918.10M | $865.10M | $99.10M | (m) | (m) | (m) | $174.50M | (m) | 1.06× |
| 2025-03-31 | $910.90M | $856.00M | $95.80M | (m) | (m) | (m) | $159.10M | (m) | 1.06× |
| 2024-12-31 | $886.90M | $841.00M | $85.40M | (m) | $593.00M | (m) | $171.00M | (m) | 1.05× |
| 2024-09-30 | $933.90M | $897.40M | $147.80M | (m) | (m) | (m) | $170.30M | (m) | 1.04× |
| 2024-06-30 | $938.10M | $694.50M | $154.40M | (m) | (m) | (m) | $164.20M | (m) | 1.35× |
| 2024-03-31 | $929.80M | $680.30M | $134.40M | (m) | (m) | (m) | $166.10M | (m) | 1.37× |
| 2023-12-31 | $841.80M | $656.40M | $69.10M | (m) | $599.80M | (m) | $170.00M | (m) | 1.28× |
| 2023-09-30 | $813.70M | $639.20M | $99.70M | (m) | (m) | (m) | $165.40M | (m) | 1.27× |
| 2023-06-30 | $824.00M | $655.00M | $117.50M | (m) | (m) | (m) | $155.80M | (m) | 1.26× |
| 2023-03-31 | $761.70M | $592.10M | $85.00M | (m) | (m) | (m) | $141.10M | (m) | 1.29× |
| 2022-12-31 | $717.20M | $575.90M | $21.80M | (m) | $524.80M | (m) | $132.90M | (m) | 1.25× |
| 2022-09-30 | $733.80M | $604.70M | $59.80M | (m) | $500.10M | (m) | $134.10M | (m) | 1.21× |
| 2022-06-30 | $1.03B | $835.40M | $186.50M | (m) | $658.70M | (m) | $138.30M | (m) | 1.24× |
| 2022-03-31 | $949.70M | $754.50M | $94.20M | (m) | $683.50M | (m) | $147.30M | (m) | 1.26× |
| 2021-12-31 | $921.40M | $748.80M | $49.40M | (m) | $502.10M | (m) | $134.00M | (m) | 1.23× |
| 2021-09-30 | $909.80M | $793.90M | $94.80M | (m) | $637.80M | (m) | $149.40M | (m) | 1.15× |
| 2021-06-30 | $859.30M | $804.50M | $73.20M | (m) | $627.50M | (m) | $145.10M | (m) | 1.07× |
| 2021-03-31 | $1.00B | $812.20M | $223.90M | (m) | $633.60M | (m) | $122.80M | (m) | 1.23× |
| 2020-12-31 | $948.60M | $717.30M | $224.00M | (m) | $563.00M | (m) | $115.00M | (m) | 1.32× |
| 2020-09-30 | $1.17B | $682.50M | $450.00M | (m) | $593.30M | (m) | $119.60M | (m) | 1.72× |
| 2020-06-30 | $1.10B | $664.40M | $419.00M | (m) | $553.20M | (m) | $93.10M | (m) | 1.66× |
| 2020-03-31 | $784.50M | $586.20M | $104.90M | (m) | $543.40M | (m) | $98.00M | (m) | 1.34× |
| 2019-12-31 | $755.80M | $721.00M | $94.80M | (m) | $498.70M | (m) | $94.60M | (m) | 1.05× |
| 2019-09-30 | $1.08B | $1.11B | $422.00M | (m) | $516.90M | (m) | $101.40M | (m) | 0.97× |
| 2019-06-30 | $844.90M | $752.90M | $221.70M | (m) | $496.00M | (m) | $95.60M | (m) | 1.12× |
| 2019-03-31 | $682.70M | $768.20M | $56.10M | (m) | $500.60M | (m) | $94.70M | (m) | 0.89× |
| 2018-12-31 | $662.10M | $672.50M | $69.20M | (m) | $459.90M | (m) | $90.00M | (m) | 0.98× |
| 2018-09-30 | $638.00M | $609.60M | $56.90M | (m) | $458.00M | (m) | $86.00M | (m) | 1.05× |
| 2018-06-30 | $671.60M | $573.90M | $59.00M | (m) | $456.60M | (m) | $85.60M | (m) | 1.17× |
| 2018-03-31 | $708.50M | $572.00M | $86.40M | (m) | $463.10M | (m) | $83.10M | (m) | 1.24× |
| 2017-12-31 | $702.20M | $517.50M | $54.40M | (m) | $459.50M | (m) | $78.40M | (m) | 1.36× |
| 2017-09-30 | $687.40M | $511.20M | $67.60M | (m) | $441.60M | (m) | $81.80M | (m) | 1.34× |
| 2017-06-30 | $693.50M | $493.30M | $71.10M | (m) | $426.50M | (m) | $77.50M | (m) | 1.41× |
| 2017-03-31 | $682.30M | $487.30M | $61.20M | (m) | $438.00M | (m) | $68.90M | (m) | 1.40× |
| 2016-12-31 | $654.50M | $475.60M | $40.50M | (m) | $432.00M | (m) | $68.30M | (m) | 1.38× |
| 2016-09-30 | $666.00M | $476.00M | $76.40M | (m) | $419.20M | (m) | $67.50M | (m) | 1.40× |
| 2016-06-30 | $659.50M | $459.10M | $70.30M | (m) | $420.60M | (m) | $67.10M | (m) | 1.44× |
| 2016-03-31 | $632.10M | $463.80M | $73.20M | (m) | $431.90M | (m) | $62.70M | (m) | 1.36× |
| 2015-12-31 | $598.70M | $426.40M | $61.60M | (m) | $403.30M | (m) | $61.60M | (m) | 1.40× |
| 2015-09-30 | $1.46B | $403.60M | $801.60M | (m) | $350.90M | (m) | $65.60M | (m) | 3.62× |
| 2015-06-30 | $712.40M | $364.60M | $45.50M | (m) | $351.80M | (m) | $60.00M | (m) | 1.95× |
| 2015-03-31 | $866.00M | $497.60M | $208.30M | (m) | $337.90M | (m) | $55.10M | (m) | 1.74× |
| 2014-12-31 | $686.60M | $364.30M | $66.70M | (m) | $323.20M | (m) | $53.40M | (m) | 1.88× |
| 2014-09-30 | $783.00M | $514.70M | $272.30M | (m) | $261.60M | (m) | $54.80M | (m) | 1.52× |
| 2014-06-30 | $580.90M | $299.30M | $65.80M | (m) | $272.30M | (m) | $55.70M | (m) | 1.94× |
| 2014-03-31 | $585.20M | $302.00M | $53.10M | (m) | $272.70M | (m) | $48.50M | (m) | 1.94× |
| 2013-12-31 | $580.40M | $311.60M | $64.50M | (m) | $261.80M | (m) | $61.90M | (m) | 1.86× |
| 2013-09-30 | $575.10M | $311.80M | $65.00M | (m) | $253.40M | (m) | $54.20M | (m) | 1.84× |
| 2013-06-30 | $591.50M | $311.60M | $68.70M | (m) | $273.70M | (m) | $57.30M | (m) | 1.90× |
| 2013-03-31 | $597.30M | $317.00M | $80.10M | (m) | $266.30M | (m) | $61.20M | (m) | 1.88× |
| 2012-12-31 | $636.80M | $300.90M | $132.80M | (m) | $249.30M | (m) | $45.30M | (m) | 2.12× |
| 2012-09-30 | $548.80M | $377.80M | $163.20M | (m) | $247.50M | (m) | $51.90M | (m) | 1.45× |
| 2012-06-30 | $424.50M | $324.60M | $41.10M | (m) | $245.70M | (m) | $59.60M | (m) | 1.31× |
| 2012-03-31 | $431.10M | $314.70M | $44.30M | (m) | $244.00M | (m) | $53.40M | (m) | 1.37× |
| 2011-12-31 | $491.60M | $313.20M | $30.10M | (m) | $222.80M | (m) | $45.40M | (m) | 1.57× |
| 2011-09-30 | $410.40M | $288.10M | $47.70M | (m) | $219.20M | (m) | $45.40M | (m) | 1.42× |
| 2011-06-30 | $428.50M | $319.10M | $60.30M | (m) | $212.80M | (m) | $45.40M | (m) | 1.34× |
| 2011-03-31 | $521.40M | $337.90M | (m) | (m) | $240.90M | (m) | $50.80M | (m) | 1.54× |
| 2010-12-31 | $406.20M | $359.30M | $48.30M | (m) | $206.70M | (m) | $44.60M | $-14.50M | 1.13× |
| 2010-09-30 | $514.30M | $390.00M | (m) | (m) | $215.20M | (m) | $49.30M | (m) | 1.32× |
| 2010-06-30 | $503.90M | $391.40M | (m) | (m) | $224.80M | (m) | $47.30M | (m) | 1.29× |
| 2009-12-31 | $426.00M | $391.20M | (m) | (m) | $219.70M | (m) | $50.20M | (m) | 1.09× |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Pediatrix Medical Group, Inc. (MD) | United States | $2.084B | 11.76 |